Shah Punit P, Mashru Rajashree C
Center of Relevance and Excellence in NDDS, Pharmacy Department, The M. S. University of Baroda, G H Patel building, Donor's Plaza, Fatehgunj, Vadodara, Gujarat 390002, India.
AAPS PharmSciTech. 2008;9(2):494-500. doi: 10.1208/s12249-008-9066-4. Epub 2008 Mar 20.
The purpose of this research was to mask the intensely bitter taste of artemether (ARM) and to formulate a rapid-disintegrating tablet (RDT) of the taste-masked drug. Taste masking was done by solid dispersion with mono amino glycyrrhyzinate pentahydrate (GLY) by solvent evaporation method. To characterize and formulate taste masked rapid disintegrating tablets (RDTs) of ARM, the 1:1M solid dispersion was selected based on bitterness score. Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), and X-ray powder diffraction (XRPD) were performed to identify the physicochemical interaction between drug and carrier, hence its effect on dissolution. RDTs were evaluated for weight variation, disintegration time, hardness and friability. In vitro drug release studies were performed for RDTs at pH 1.2 and 6.8. Bitterness score was evaluated using mini-column method and compared with gustatory sensation test. FTIR spectroscopy and DSC showed no interaction while XRPD showed amorphization of ARM in GLY solid dispersion. RDTs prepared using solid dispersion, (RDT3), showed faster disintegration (within 28 s) and complete bitter taste masking of ARM. In addition, RDT3 exhibited better dissolution profile at both pH 1.2 and 6.8, than RDTs prepared from pure ARM (RDT5). Taste evaluation of RDTs in human volunteers rated tasteless with a score of 0 to RDT3 and 3 to RDT5. Mini-column revealed that RDT5 showed increase in number of persons who sensed bitterness with increased amount of ARM release while RDT3 sensed no bitterness. Thus, results conclusively demonstrated successful masking of taste and rapid disintegration of the formulated tablets in the oral cavity with improved dissolution.
本研究的目的是掩盖蒿甲醚(ARM)强烈的苦味,并制备该掩味药物的速崩片(RDT)。通过溶剂蒸发法将ARM与五水单氨基甘草酸盐(GLY)进行固体分散来实现掩味。为了表征和制备ARM的掩味速崩片(RDT),根据苦味评分选择了1:1M的固体分散体。采用傅里叶变换红外光谱(FTIR)、差示扫描量热法(DSC)和X射线粉末衍射(XRPD)来确定药物与载体之间的物理化学相互作用,以及其对溶出度的影响。对RDT进行了重量差异、崩解时间、硬度和脆碎度的评估。在pH 1.2和6.8条件下对RDT进行了体外药物释放研究。使用微型柱法评估苦味评分,并与味觉测试进行比较。FTIR光谱和DSC显示无相互作用,而XRPD显示ARM在GLY固体分散体中呈非晶态。使用固体分散体制备的RDT(RDT3)显示出更快的崩解(在28秒内),并完全掩盖了ARM的苦味。此外,与由纯ARM制备的RDT(RDT5)相比,RDT3在pH 1.2和6.8条件下均表现出更好的溶出曲线。对人类志愿者的RDT味觉评估显示,RDT3评分为无味(0分),RDT5评分为3分。微型柱显示,随着ARM释放量的增加,RDT5中感觉到苦味的人数增加,而RDT3未感觉到苦味。因此,结果最终证明了所制备片剂在口腔中成功实现了掩味和快速崩解,且溶出度有所提高。